Anebulo Pharmaceuticals (ANEB) Earnings Date & Reports

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANEB is expected to report earnings to rise 25.00% to -5 cents per share on September 17

Anebulo Pharmaceuticals ANEB Stock Earnings Reports

Q2'25

Est.

$-0.05

Q1'25

Beat

by $0.04

Q4'24

Missed

by $0.01

Q3'24

Missed

by $0.03

Q2'24

Beat

by $0.06

The last earnings report on May 13 showed earnings per share of -3 cents, beating the estimate of -7 cents. With 150.00 shares outstanding, the current market capitalization sits at 45.60M.

View a ticker or compare two or three

Compare

ANEB